Advanced Genetic Testing (old page)
Advanced Genetic Testing
Sophisticated expertise in clinical genetics
Rare diseases or difficult diagnoses are frequently best understood with genetics. Patient stratification by pharmacogenetic profiling or other methods (e.g., custom gene panels) can maximize the odds of a successful clinical trial. We also build custom assays for difficult genetic elements such as pseudogenes, tandem repeats, and structural variants (including deletions, duplications, inversions, translocations, and insertions). We know that human clinical genetics can be quite complex due to the different types of inheritance (e.g., recessive, dominant, X-linked, mitochondrial, partial penetrance), variants and terminology (e.g., indels, copy number variants, single nucleotide variants, polymorphisms, mutations) and many different methods and platforms available for analyses. We offer clinical genetic consulting services to 1) help our clients understand the literature relevant to their patients or their disorders of interest, and 2) to demystify the different detection methods available with their respective costs/benefits along with our recommendations. Additionally, we also provide bioinformatic services or variant analyses to clients who already have their own data.
We have a sophisticated expertise in clinical genetics characterizing germline (i.e., inherited or constitutional) and somatic genetic disorders or infectious disease, using:
- Founded in 2003
- 50-person company, 2 CAP/CLIA sites
- 70% of staff have advanced degree or are board certified (top programs)
- 25% of staff are trained CAP inspectors
- CA medical director is a key opinion leader in TMAs, benign hematology disorders and kidney diseases
- Louisiana medical director is a nationally recognized pathology expert in thrombosis and hemostasis
- Existing relationships with hospital systems in 50 states and 17 countries
- Clients include small, medium and large pharma, biotech, CROs for local to global studies
Jihyun Moon, Ph.D.
Senior Clinical Research Scientist
Jihyun leads the design and validation of new genetic panels. She also analyzes the NGS data and writes the clinical reports for many of our panels. Jihyun is a subject matter expert on the genetics of bleeding, clotting and platelet disorders.
Before joining Machaon in 2018, Jihyun was the Chief Scientific Officer at the synthetic biology startup TAXA, Inc., where she developed a plant metabolic engineering platform. Jihyun has published her studies on the developmental biology of maize from her time in academia.
Jihyun Moon, PhD
BS
MS
PhD
Post–doctoral Scholar
Seoul National University
Seoul National University
University of California, Berkeley
University of California, Berkeley
Frances Tran, Ph.D.
Frances Tran, Ph.D.
Senior Clinical Research Scientist
Frances is the head of our Covid-19 testing team and our infectious disease group. She rapidly built a Covid-19 testing operation at Machaon that is able to complete the vast majority of tests with same-day turnaround time. Her efforts helped many local schools and businesses remain open during the pandemic, including our own.
In her previous work at Curative, Inc., Frances was a key player in bringing large-scale Covid-19 testing to Los Angeles. During her academic training, Frances published on vesicle-mediated horizontal gene transfer in bacteria.
BA
PhD
Post–doctoral Scholar
Seoul National University
Seoul National University
University of California, Berkeley
University of California, Berkeley